Click here to close now.


News Feed Item

Los Angeles Research Sites Investigating Medical Device Proven to Restore Vision and Improve Quality of Life in Seniors

Drs. David Boyer and Samuel Masket Now Enrolling Patients for the CentraSight Study

LOS ANGELES, CA -- (Marketwired) -- 08/18/14 -- Dr. David Boyer with Retina-Vitreous Associates Medical Group and Dr. Samuel Masket with Advanced Vision Care today announced they are participating in a nationwide, post-approval study of the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), a medical device already approved by the FDA to restore vision and improve quality of life in people living with end-stage age-related macular degeneration (AMD) and meeting specific vision and cornea health criteria.

The study is designed to corroborate the safety data submitted to the U.S. Food and Drug Administration that led to approval and evaluate the patient care program in a commercial setting. Both Retina-Vitreous Associates Medical Group and Advanced Vision are actively seeking patients to participate in the telescope implant treatment program.

Smaller than a pea, the telescope implant uses micro-optical technology to magnify images which would normally be seen in one's straight ahead vision. The images are projected onto the healthy portion of the retina not affected by the disease, making it possible for patients to see or discern the central vision object of interest.

The CentraSight® program has been developed to help patients see the things that are important to them, regain independence, and re-engage in everyday activities. The program utilizes a multispecialty provider team approach to help patients follow the necessary steps for proper diagnosis, surgical evaluation, and postoperative care. The specially trained team includes a retina specialist, cornea surgeon, low vision optometrist and low vision occupational therapist, the latter whom works with the patient over several months to teach them how to use his/her new vision. The telescope implant is the only approved surgical device for end-stage AMD and the treatment is Medicare eligible.

"We have been offering the telescope implant surgery to patients in the LA metro area since 2011," said Dr. Samuel Masket. "We've been impressed with patients' progress following the out-patient procedure as they become proficient in using this remarkable, implanted device. Patients report they are resuming hobbies, living more independently and, most importantly, seeing the faces of their family and friends."

About End-Stage AMD

More than 15 million Americans are affected by some form of macular degeneration and approximately 2 million Americans have advanced forms of AMD with associated vision loss. The number of Americans afflicted with macular degeneration is expected to double with the rapid aging of the U.S. population. Specifically, end-stage AMD results in a loss of central or "straight-ahead" vision, creating a blind spot, and is uncorrectable by glasses, drugs or cataract surgery. This blind spot makes it difficult or impossible for patients to see faces, read, and perform everyday activities such as watching TV, preparing meals, and self-care. The telescope implant has been demonstrated in earlier clinical trials to improve quality of life for those with central vision loss in both eyes by improving patients' vision so they can see the things that are important to them, increase their independence, and re-engage in everyday activities. It also may help patients in social settings as it may allow them to recognize faces and see the facial expressions of family and friends.

Retina-Vitreous Associates Medical Group and Advanced Vision Care are actively seeking patients whom might be candidates for the telescope implant. Upon contacting either of these practices, patients will be evaluated for the study participation by determining if they:

  • Have irreversible, End-Stage AMD resulting from either dry or wet AMD in both eyes
  • Are no longer a candidate for drug treatment
  • Have not had cataract surgery in the eye where the telescope will be implanted and have adequate peripheral vision in the eye not scheduled for surgery
  • Are age 75 or older and meet other vision/cornea health requirements

The CentraSight treatment program in Los Angeles includes Dr. David Boyer, who coordinates the treatment; Dr. Samuel Masket, who performs the surgery at Good Samaritan Hospital; and the Center for Partially Sighted, who coordinates the post-surgical rehabilitation for the patient.

The telescope implant is not a cure for End-stage AMD. As with any medical intervention, potential risks and complications exist with the telescope implant. Possible side effects include decreased vision or vision impairing corneal swelling. The risks and benefits associated with the telescope implant are discussed in the Patient Information Booklet available at and will be evaluated with each patient who might be a candidate for this study.

Patients and physicians can find more information about the telescope implant and related treatment program by calling Advanced Vision Care at 310-229-1220 or by visiting or calling 1-877-99-SIGHT.

About Advanced Vision Care

Advanced Vision Care is dedicated to providing state-of-the-art, individually based, high quality, eye health care. Drs. Samuel Masket, Nicole Fram and Juliet Chung are board-certified skilled ophthalmologists that provide a variety of services to help you attain the clearest vision possible. Our services cover a range of eye problems including cataracts, glaucoma, corneal disease and dry eye, retinal disorders, and ocular injuries. We have the common goal of ascertaining the most appropriate care for any given patient, explaining the purpose of the treatment, and in initiating said therapy in a courteous and compassionate manner irrespective of age, gender, nationality, race, or payment program. For more information, go to

About Retina-Vitreous Associates Medical Group

Retina-Vitreous Associates Medical Group specializes in the treatment of diseases affecting the back of the eye, specifically those of the retina, vitreous, and macula. Patients are typically referred by their general ophthalmologist when a retinal problem is suspected. They care for patients with macular degeneration, diabetic retinopathy, retinal detachment, retinal vein occlusions, uveitis, ocular tumors and pediatric retinal diseases.

They have seven office locations. Each is equipped with state of the art diagnostic equipment and treatment facilities. RVAMG is also extremely active in clinical research, community education and participates in a number of various clinical studies evaluating new treatments. They are dedicated to providing the best possible care, and can provide patient access to the most current treatment options. For more information, go

About CentraSight

CentraSight is a first-of-kind treatment program that utilizes a tiny telescope implant for End-stage age-related macular degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans. Patients with End-stage AMD have a central blind spot or missing area in their vision that makes it difficult or impossible to see faces, read, and perform everyday activities. The CentraSight treatment program allows patients to see details again by implanting a tiny telescope in the eye in an outpatient procedure, then coordinating with low vision specialists to help the patient learn how to use their new vision for everyday activities. For more information, visit

Media Contact:

Jennifer Heinly
J&J Consulting
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
"eFolder does a lot of different things but we protect data and we are focused on protecting data no matter where it resides," explained Carlo Tapia, Product Marketing Manager at eFolder, in this interview at Cloud Expo, held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA.
The Internet of Things (IoT) is growing rapidly by extending current technologies, products and networks. By 2020, Cisco estimates there will be 50 billion connected devices. Gartner has forecast revenues of over $300 billion, just to IoT suppliers. Now is the time to figure out how you’ll make money – not just create innovative products. With hundreds of new products and companies jumping into the IoT fray every month, there’s no shortage of innovation. Despite this, McKinsey/VisionMobile data...
Cloud computing is unquestionably one of the driving forces of DevOps, as the automation of operations transforms enterprise software development. DevOps, however, is more than a technology trend, as it represents a move toward silo-busting, self-organizing horizontal teams that drive business velocity. At the same time, enterprise Digital Transformation represents an upheaval across the enterprise, as customer preferences and behavior drive enterprise technology decisions. This transformation ...
Just over a week ago I received a long and loud sustained applause for a presentation I delivered at this year’s Cloud Expo in Santa Clara. I was extremely pleased with the turnout and had some very good conversations with many of the attendees. Over the next few days I had many more meaningful conversations and was not only happy with the results but also learned a few new things. Here is everything I learned in those three days distilled into three short points.
Most of the IoT Gateway scenarios involve collecting data from machines/processing and pushing data upstream to cloud for further analytics. The gateway hardware varies from Raspberry Pi to Industrial PCs. The document states the process of allowing deploying polyglot data pipelining software with the clear notion of supporting immutability. In his session at @ThingsExpo, Shashank Jain, a development architect for SAP Labs, discussed the objective, which is to automate the IoT deployment proces...
In demand-intensive mobile and web applications, an emerging pattern is to host the Systems of Engagement in the cloud (for maximum responsiveness) but keep the Systems of Record with the other important business systems in the company datacenter, often on a tightly secured mainframe. But what about the space in between? In this IBM Redpaper publication, we show that the IBM Bluemix cloud platform offers technologies that make it easy for cloud-based SoEs to securely connect to on-premises IBM...
DevOps is about increasing efficiency, but nothing is more inefficient than building the same application twice. However, this is a routine occurrence with enterprise applications that need both a rich desktop web interface and strong mobile support. With recent technological advances from Isomorphic Software and others, rich desktop and tuned mobile experiences can now be created with a single codebase – without compromising functionality, performance or usability. In his session at DevOps Su...
As organizations realize the scope of the Internet of Things, gaining key insights from Big Data, through the use of advanced analytics, becomes crucial. However, IoT also creates the need for petabyte scale storage of data from millions of devices. A new type of Storage is required which seamlessly integrates robust data analytics with massive scale. These storage systems will act as “smart systems” provide in-place analytics that speed discovery and enable businesses to quickly derive meaningf...
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
In his General Session at 17th Cloud Expo, Bruce Swann, Senior Product Marketing Manager for Adobe Campaign, explored the key ingredients of cross-channel marketing in a digital world. Learn how the Adobe Marketing Cloud can help marketers embrace opportunities for personalized, relevant and real-time customer engagement across offline (direct mail, point of sale, call center) and digital (email, website, SMS, mobile apps, social networks, connected objects).
OpsHub, Inc. has announced enhanced support for DevOps and Migration for both Team Foundation Server and Visual Studio On-line in a heterogeneous environment. With added support for build and release entities in OpsHub Integration Manager (OIM) Microsoft customers can now leverage Visual Studio build and release services to manage DevOps processes in a heterogeneous environment. With the enhanced support customers can manage the DevOps process in Team Foundation Server while undertaking activit...
The buzz continues for cloud, data analytics and the Internet of Things (IoT) and their collective impact across all industries. But a new conversation is emerging - how do companies use industry disruption and technology enablers to lead in markets undergoing change, uncertainty and ambiguity? Organizations of all sizes need to evolve and transform, often under massive pressure, as industry lines blur and merge and traditional business models are assaulted and turned upside down. In this new da...
SYS-CON Events announced today that Catchpoint, a global leader in monitoring, and testing the performance of online applications, has been named "Silver Sponsor" of DevOps Summit New York, which will take place on June 7-9, 2016 at the Javits Center in New York City. Catchpoint radically transforms the way businesses manage, monitor, and test the performance of online applications. Truly understand and improve user experience with clear visibility into complex, distributed online systems.Founde...
With all the incredible momentum behind the Internet of Things (IoT) industry, it is easy to forget that not a single CEO wakes up and wonders if “my IoT is broken.” What they wonder is if they are making the right decisions to do all they can to increase revenue, decrease costs, and improve customer experience – effectively the same challenges they have always had in growing their business. The exciting thing about the IoT industry is now these decisions can be better, faster, and smarter. Now ...
In recent years, at least 40% of companies using cloud applications have experienced data loss. One of the best prevention against cloud data loss is backing up your cloud data. In his General Session at 17th Cloud Expo, Sam McIntyre, Partner Enablement Specialist at eFolder, presented how organizations can use eFolder Cloudfinder to automate backups of cloud application data. He also demonstrated how easy it is to search and restore cloud application data using Cloudfinder.